|
1
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar
|
|
2
|
Miyamoto S, Nakanishi M and Rosenberg DW:
Suppression of colon carcinogenesis by targeting Notch signaling.
Carcinogenesis. 34:2415–2423. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Katoh M and Katoh M: Notch signaling in
gastrointestinal tract (Review). Int J Oncol. 30:247–251. 2007.
|
|
4
|
Prasetyanti PR, Zimberlin CD, Bots M,
Vermeulen L, Melo FS and Medema JP: Regulation of stem cell
self-renewal and differentiation by Wnt and Notch are conserved
throughout the adenoma-carcinoma sequence in the colon. Mol Cancer.
12:1262013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reedijk M, Odorcic S, Zhang H, Chetty R,
Tennert C, Dickson BC, Lockwood G, Gallinger S and Egan SE:
Activation of Notch signaling in human colon adenocarcinoma. Int J
Oncol. 33:1223–1229. 2008.PubMed/NCBI
|
|
6
|
Zhang Y, Li B, Ji ZZ and Zheng PS: Notch1
regulates the growth of human colon cancers. Cancer. 116:5207–5218.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mumm JS and Kopan R: Notch signaling: from
the outside in. Dev Biol. 228:151–165. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li JL and Harris AL: Notch signaling from
tumor cells: a new mechanism of angiogenesis. Cancer Cell. 8:1–3.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iso T, Kedes L and Hamamori Y: HES and
HERP families: multiple effectors of the Notch signaling pathway. J
Cell Physiol. 194:237–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bhanot U, Köhntop R, Hasel C and Möller P:
Evidence of Notch pathway activation in the ectatic ducts of
chronic pancreatitis. J Pathol. 214:312–319. 2008. View Article : Google Scholar
|
|
11
|
Ehebauer M, Hayward P and Arias AM: Notch,
a universal arbiter of cell fate decisions. Science. 314:1414–1415.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garin JP, Despeignes J and Billerau M:
Present treatment of taeniasis with niclosamide. Lyon Med.
212:1581–1588. 1964.In French. PubMed/NCBI
|
|
13
|
Jin Y, Lu Z, Ding K, Li J, Du X, Chen C,
Sun X, Wu Y, Zhou J and Pan J: Antineoplastic mechanisms of
niclosamide in acute myelogenous leukemia stem cells: inactivation
of the NF-kappaB pathway and generation of reactive oxygen species.
Cancer Res. 70:2516–2527. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sack U, Walther W, Scudiero D, Selby M,
Kobelt D, Lemm M, Fichtner I, Schlag PM, Shoemaker RH and Stein U:
Novel effect of antihelminthic niclosamide on S100A4-mediated
metastatic progression in colon cancer. J Natl Cancer Inst.
103:1018–1036. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wieland A, Trageser D, Gogolok S, Reinartz
R, Höfer H, Keller M, Leinhaas A, Schelle R, Normann S, Klaas L, et
al: Anticancer effects of niclosamide in human glioblastoma. Clin
Cancer Res. 19:4124–4136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ye T, Xiong Y, Yan Y, Xia Y, Song X, Liu
L, Li D, Wang N, Zhang L and Zhu Y: et al The anthelmintic drug
niclosamide induces apoptosis, impairs metastasis and reduces
immunosuppressive cells in breast cancer model. PLoS One.
9:e858872014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Z, Li Y, Kong D, Ahmad A, Banerjee S
and Sarkar FH: Cross-talk between miRNA and Notch signaling
pathways in tumor development and progression. Cancer Lett.
292:141–148. 2010. View Article : Google Scholar
|
|
18
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Denli AM, Tops BB, Plasterk RH, Ketting RF
and Hannon GJ: Processing of primary microRNAs by the
Microprocessor complex. Nature. 432:231–235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Prokopi M, Kousparou CA and Epenetos AA:
The secret role of microRNAs in cancer stem cell development and
potential therapy: a Notch-pathway approach. Front Oncol.
4:3892015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Srinivasan S, Selvan ST, Archunan G,
Gulyas B and Padmanabhan P: MicroRNAs -the next generation
therapeutic targets in human diseases. Theranostics. 3:930–942.
2013. View Article : Google Scholar
|
|
22
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Korpal M and Kang Y: The emerging role of
miR-200 family of microRNAs in epithelial-mesenchymal transition
and cancer metastasis. RNA Biol. 5:115–119. 2008. View Article : Google Scholar
|
|
24
|
Brabletz S, Bajdak K, Meidhof S, Burk U,
Niedermann G, Firat E, Wellner U, Dimmler A, Faller G, Schubert J
and Brabletz T: The ZEB1/miR-200 feedback loop controls Notch
signalling in cancer cells. EMBO J. 30:770–782. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Burk U, Schubert J, Wellner U, Schmalhofer
O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression
between ZEB1 and members of the miR-200 family promotes EMT and
invasion in cancer cells. EMBO Rep. 9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vallejo DM, Caparros E and Dominguez M:
Targeting Notch signalling by the conserved miR-8/200 microRNA
family in development and cancer cells. EMBO J. 30:756–769. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Z, Banerjee S, Ahmad A, Li Y, Azmi
AS, Gunn JR, Kong D, Bao B, Ali S, Gao J, et al: Activated K-ras
and INK4a/Arf deficiency cooperate during the development of
pancreatic cancer by activation of Notch and NF-κB signaling
pathways. PLoS One. 6:e205372011. View Article : Google Scholar
|
|
28
|
Ferrari-Toninelli G, Bonini SA, Uberti D,
Buizza L, Bettinsoli P, Poliani PL, Facchetti F and Memo M:
Targeting Notch pathway induces growth inhibition and
differentiation of neuroblastoma cells. Neuro Oncol. 12:1231–1243.
2010.PubMed/NCBI
|
|
29
|
Rasul S, Balasubramanian R, Filipović A,
Slade MJ, Yagüe E and Coombes RC: Inhibition of gamma-secretase
induces G2/M arrest and triggers apoptosis in breast cancer cells.
Br J Cancer. 100:1879–1888. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Senfter D, Holzner S, Kalipciyan M,
Staribacher A, Walzl A, Huttary N, Krieger S, Brenner S, Jäger W,
Krupitza G, et al: Loss of miR-200 family in 5-fluorouracil
resistant colon cancer drives lymphendothelial invasiveness in
vitro. Hum Mol Genet. 24:3689–3698. 2015.PubMed/NCBI
|
|
31
|
Li Y, Li PK, Roberts MJ, Arend RC, Samant
RS and Buchsbaum DJ: Multi-targeted therapy of cancer by
niclosamide: a new application for an old drug. Cancer Lett.
349:8–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pastò A, Serafin V, Pilotto G, Lago C,
Bellio C, Trusolino L, Bertotti A, Hoey T, Plateroti M, Esposito G,
et al: NOTCH3 signaling regulates MUSASHI-1 expression in
metastatic colorectal cancer cells. Cancer Res. 74:2106–2118. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ranganathan P, Weaver KL and Capobianco
AJ: Notch signalling in solid tumours: a little bit of everything
but not all the time. Nat Rev Cancer. 11:338–351. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dai Y, Wilson G, Huang B, Peng M, Teng G,
Zhang D, Zhang R, Ebert MP, Chen J, Wong BC, et al: Silencing of
Jagged1 inhibits cell growth and invasion in colorectal cancer.
Cell Death Dis. 5:e11702014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ozawa T, Kazama S, Akiyoshi T, Murono K,
Yoneyama S, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Nozawa H, et
al: Nuclear Notch3 expression is associated with tumor recurrence
in patients with stage II and III colorectal cancer. Ann Surg
Oncol. 21:2650–2658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shih IeM and Wang TL: Notch signaling,
gamma-secretase inhibitors, and cancer therapy. Cancer Res.
67:1879–1882. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Balgi AD, Fonseca BD, Donohue E, Tsang TC,
Lajoie P, Proud CG, Nabi IR and Roberge M: Screen for chemical
modulators of autophagy reveals novel therapeutic inhibitors of
mTORC1 signaling. PLoS One. 4:e71242009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Osada T, Chen M, Yang XY, Spasojevic I,
Vandeusen JB, Hsu D, Clary BM, Clay TM, Chen W, Morse MA and Lyerly
HK: Antihelminth compound niclosamide downregulates Wnt signaling
and elicits antitumor responses in tumors with activating APC
mutations. Cancer Res. 71:4172–4182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang AM, Ku HH, Liang YC, Chen YC, Hwu YM
and Yeh TS: The autonomous notch signal pathway is activated by
baicalin and baicalein but is suppressed by niclosamide in K562
cells. J Cell Biochem. 106:682–692. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fernández-Majada V, Aguilera C, Villanueva
A, Vilardell F, Robert-Moreno A, Aytés A, Real FX, Capella G, Mayo
MW, Espinosa L and Bigas A: Nuclear IKK activity leads to
dysregulated notch-dependent gene expression in colorectal cancer.
Proc Natl Acad Sci USA. 104:276–281. 2007. View Article : Google Scholar :
|
|
41
|
Qiao L and Wong BC: Role of Notch
signaling in colorectal cancer. Carcinogenesis. 30:1979–1986. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jones KB, Salah Z, Del Mare S, Galasso M,
Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, et
al: miRNA signatures associate with pathogenesis and progression of
osteosarcoma. Cancer Res. 72:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kobayashi E, Hornicek FJ and Duan Z:
MicroRNA involvement in osteosarcoma. Sarcoma. 2012:3597392012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kong D, Li Y, Wang Z, Banerjee S, Ahmad A,
Kim HR and Sarkar FH: miR-200 regulates PDGF-D-mediated
epithelial-mesenchymal transition, adhesion, and invasion of
prostate cancer cells. Stem Cells. 27:1712–1721. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li Y, VandenBoom TG II, Kong D, Wang Z,
Ali S, Philip PA and Sarkar FH: Up-regulation of miR-200 and let-7
by natural agents leads to the reversal of
epithelial-to-mesenchymal transition in gemcitabine-resistant
pancreatic cancer cells. Cancer Res. 69:6704–6712. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
